Gould Capital, LLC Emergent Bio Solutions Inc. Transaction History
Gould Capital, LLC
- $151 Million
- Q3 2024
A detailed history of Gould Capital, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Gould Capital, LLC holds 100 shares of EBS stock, worth $1,102. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$1,102
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EBS
# of Institutions
156Shares Held
33.7MCall Options Held
453KPut Options Held
931K-
Black Rock Inc. New York, NY3.84MShares$42.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$37.4 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.49MShares$27.5 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA2.22MShares$24.5 Million0.0% of portfolio
-
State Street Corp Boston, MA1.91MShares$21.1 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $549M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...